Status:
RECRUITING
Opioid Misuse in Patients with Cancer
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Cancer
Opioid Use
Eligibility:
All Genders
18+ years
Brief Summary
The success of opioid treatment in terminally ill cancer patients set the stage for extending the same treatment principles to the treatment of all chronic pain conditions including chronic non-cancer...
Detailed Description
This is a prospective and cross-sectional study, in which opioid misuse is defined according to National Institute on Drug Abuse (USA) as the use of prescription opioids in a manner other than as dire...
Eligibility Criteria
Inclusion
- Outpatients ≥ 18 years,
- patients who are treated with opioids due to cancer-related pain.
Exclusion
- Patients who do not master the Danish language in speech and writing,
- Patients who have severe cognitive dysfunction,
- Patients who are not treated with opioids,
- Patients who refused to participate in the study.
Key Trial Info
Start Date :
January 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06489769
Start Date
January 15 2025
End Date
December 31 2025
Last Update
March 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, København Ø., Denmark, 2100